• OPEN AN ACCOUNT
Indian Indices
Nifty
22,442.70 -33.15
(-0.15%)
Sensex
73,895.54 17.39
( 0.02%)
Bank Nifty
48,895.30 -28.25
( -0.06%)
Nifty IT
33,217.15 308.75
( 0.94%)
Global Indices
Nasdaq
16,156.33 315.37
(1.99%)
Dow Jones
38,675.68 450.02
(1.18%)
Hang Seng
18,578.30 102.38
(0.55%)
Nikkei 225
38,236.07 -37.98
(-0.10%)
Forex
USD-INR
83.43 -0.03
(-0.04%)
EUR-INR
89.37 0.26
(0.29%)
GBP-INR
104.48 0.21
(0.20%)
JPY-INR
0.54 0.01
(1.69%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Dr Reddys Laboratories Ltd
Dr. Reddy's launches condition management programme DailyBloom™ IBS
Apr 19,2024
Dr. Reddy's Laboratories announced the roll-out of its condition management programme DailyBloom™ IBS, India's first integrated care plan for Irritable Bowel Syndrome (IBS). The programme is based on extensive research and is enabled by a mobile application developed in-house. DailyBloom™ IBS focuses on a comprehensive care plan that includes diet management, psychological and physical wellness support for patients with IBS. Dr. Reddy's has launched the programme on ‘World IBS Day', a day that aims to increase awareness of the IBS condition, discuss misconceptions, challenges and even stigma attached to it.